@article{article, title = {{The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model.}}, url = {{}}, year = {{2013}}, month = {{4}}, author = {{Hoyle M and Crathorne L and Peters J and Jones-Hughes T and Cooper C and Napier M and Tappenden P and Hyde C}}, doi = {{10.3310/hta17140}}, volume = {{17}}, journal = {{Health Technol Assess}}, issue = {{14}}, pages = {{1-237}}, note = {{Accessed on 2025/09/23}}}